Mexico's Cofepris Approves Lenacapavir for HIV Prevention

Mexico's health regulator Cofepris authorized the sanitary registration of lenacapavir, a long-acting antiretroviral for HIV pre-exposure prophylaxis. This expands access to a novel prevention tool in a country with significant HIV burden, though rollout details and pricing remain unclear. The approval signals regulatory openness to innovative HIV prevention in Latin America.